Mubadala, US-based Resilience to manufacture biopharma in UAE
Mubadala Investment Company (Mubadala), an Abu Dhabi sovereign investor, and US-based National Resilience (Resilience), a technology-focused manufacturing company, have signed a deal to further advance the UAE’s life sciences ecosystem through biopharma manufacturing. National Resilience is a biotechnology company headquartered in California in the US that is building a network…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Gulf Business